Neurosearch

Ballerup, Denmark Founded: 1989 • Age: 37 yrs
Develops pharmaceutical agents targeting ion channels and central nervous system disorders.
Annual revenue - Latest available
Total funding - 1 rounds
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About Neurosearch

Neurosearch is a company based in Ballerup (Denmark) founded in 1989. It operates as a B2B. Neurosearch operates in a competitive market with competitors including Biogen, Denali Therapeutics, Annexon, Entrada Therapeutics and Adamas Pharma, among others.

  • Headquarter Ballerup, Denmark
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    $14.33 M (USD), Post-IPO

    Aug 17, 2009

  • Investors
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Neurosearch

Investors in Neurosearch

Neurosearch has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Johnson & Johnson Innovation – JJDC.

All
Venture Fund
Investor Description Founded Year Domain Location
Venture capital firm backed by Johnson & Johnson
Locked Locked Locked
Premium access

Investor details for Neurosearch

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Neurosearch

Investments
Premium access

Investment portfolio details for Neurosearch

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Neurosearch

Premium access

Detailed financials for Neurosearch

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Neurosearch Comparisons

Neurosearch Primary company
Description
Develops pharmaceutical agents targeting ion channels and ce...
Location
Ballerup, Denmark
Founded Year
1989
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Neurosearch

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Neurosearch

Neurosearch operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biogen, Denali Therapeutics, Annexon, Entrada Therapeutics and Adamas Pharma, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Therapies for neurodegenerative and immunology disorders are developed.
Locked Locked Locked
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
Locked Locked Locked
Developer of antibodies to treat complement-mediated neurodegenerative diseases
Locked Locked Locked
Biologics platform developed for intracellular delivery in rare diseases.
Locked Locked Locked
Pharmacokinetic profiles of approved drugs are enhanced for CNS therapeutics.
Locked Locked Locked
T-cell-based therapies for autoimmune and degenerative diseases are developed.
Premium access

Detailed competitors of Neurosearch

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Neurosearch

Premium access

Complete news archive for Neurosearch

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neurosearch

Neurosearch was founded in 1989 and raised its 1st funding round 20 years after it was founded.

Neurosearch is headquartered in Ballerup, Denmark.

Neurosearch, established in 1989, excels in healthcare and pharmaceuticals, advancing biotech innovations, drug development, and cns disorders. Develops pharmaceutical agents targeting ion channels and central nervous system disorders. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.

Neurosearch's top competitors include Alector, Intra-Cellular Therapies and Entrada Therapeutics.

Neurosearch has 1 investor. Key investors include Johnson & Johnson Innovation – JJDC.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available